INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 270 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $39,872,386 | +44.5% | 711,118 | +9.1% | 0.01% | +42.9% |
| Q3 2022 | $27,599,319 | -17.8% | 651,542 | +4.8% | 0.01% | -22.2% |
| Q2 2022 | $33,592,882 | -20.1% | 621,745 | -5.0% | 0.01% | 0.0% |
| Q1 2022 | $42,067,552 | -7.1% | 654,646 | -3.2% | 0.01% | 0.0% |
| Q4 2021 | $45,302,000 | +44.7% | 676,254 | +48.0% | 0.01% | +28.6% |
| Q3 2021 | $31,299,000 | -34.5% | 457,056 | -34.8% | 0.01% | -30.0% |
| Q2 2021 | $47,808,000 | -1.9% | 700,581 | -0.6% | 0.01% | -9.1% |
| Q1 2021 | $48,716,000 | +5.2% | 705,112 | -1.1% | 0.01% | 0.0% |
| Q4 2020 | $46,303,000 | +56.0% | 713,230 | +13.5% | 0.01% | +37.5% |
| Q3 2020 | $29,674,000 | -15.1% | 628,413 | -15.5% | 0.01% | -20.0% |
| Q2 2020 | $34,946,000 | +6.5% | 743,686 | +1.3% | 0.01% | -16.7% |
| Q1 2020 | $32,810,000 | -22.3% | 734,491 | +1.4% | 0.01% | 0.0% |
| Q4 2019 | $42,202,000 | -3.0% | 724,131 | 0.0% | 0.01% | -7.7% |
| Q3 2019 | $43,498,000 | +8.8% | 724,131 | +1.1% | 0.01% | +8.3% |
| Q2 2019 | $39,991,000 | -2.5% | 716,042 | -2.7% | 0.01% | -7.7% |
| Q1 2019 | $41,006,000 | +27.6% | 735,936 | +3.3% | 0.01% | +8.3% |
| Q4 2018 | $32,141,000 | -31.5% | 712,664 | 0.0% | 0.01% | -20.0% |
| Q3 2018 | $46,944,000 | +2.3% | 712,664 | 0.0% | 0.02% | -6.2% |
| Q2 2018 | $45,903,000 | +49.1% | 712,664 | +28.1% | 0.02% | +45.5% |
| Q1 2018 | $30,793,000 | +22.2% | 556,434 | +5.7% | 0.01% | +22.2% |
| Q4 2017 | $25,201,000 | -6.0% | 526,569 | -0.8% | 0.01% | -10.0% |
| Q3 2017 | $26,801,000 | +1.5% | 530,916 | +9.6% | 0.01% | 0.0% |
| Q2 2017 | $26,396,000 | +58.3% | 484,241 | +22.4% | 0.01% | +42.9% |
| Q1 2017 | $16,672,000 | -47.5% | 395,723 | +6.9% | 0.01% | -50.0% |
| Q4 2016 | $31,772,000 | -21.3% | 370,344 | -27.7% | 0.01% | -26.3% |
| Q3 2016 | $40,364,000 | +0.8% | 511,950 | +2.0% | 0.02% | 0.0% |
| Q2 2016 | $40,046,000 | +7.2% | 501,950 | -9.5% | 0.02% | +5.6% |
| Q1 2016 | $37,348,000 | -0.6% | 554,457 | 0.0% | 0.02% | -5.3% |
| Q4 2015 | $37,581,000 | +65.0% | 554,457 | +45.0% | 0.02% | +58.3% |
| Q3 2015 | $22,771,000 | +6.6% | 382,377 | +20.6% | 0.01% | +9.1% |
| Q2 2015 | $21,368,000 | +9.3% | 317,177 | 0.0% | 0.01% | +10.0% |
| Q1 2015 | $19,554,000 | +26.4% | 317,177 | +11.1% | 0.01% | +25.0% |
| Q4 2014 | $15,476,000 | +54.9% | 285,377 | +41.8% | 0.01% | +60.0% |
| Q3 2014 | $9,994,000 | -47.3% | 201,317 | -50.0% | 0.01% | 0.0% |
| Q2 2014 | $18,948,000 | +104.6% | 402,634 | +100.0% | 0.01% | 0.0% |
| Q1 2014 | $9,259,000 | -3.6% | 201,317 | 0.0% | 0.01% | -16.7% |
| Q4 2013 | $9,605,000 | +18.5% | 201,317 | 0.0% | 0.01% | +20.0% |
| Q3 2013 | $8,103,000 | +48.7% | 201,317 | +35.3% | 0.01% | +66.7% |
| Q2 2013 | $5,451,000 | +48.9% | 148,816 | +58.5% | 0.00% | +50.0% |
| Q1 2013 | $3,662,000 | -5.1% | 93,866 | 0.0% | 0.00% | -33.3% |
| Q3 2012 | $3,858,000 | +6.9% | 93,866 | 0.0% | 0.00% | 0.0% |
| Q2 2012 | $3,610,000 | – | 93,866 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
| Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
| Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
| KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
| Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
| Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
| Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
| COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |